Spiradenomas are benign cutaneous adnexal neoplasms with sweat gland differentiation that can manifest a broad spectrum of histomorphologic appearances. While they show a characteristic histopathologic phenotype and clinical management involves surgical excision with a low risk of recurrence, there have been unusual histopathologic variants of spiradenoma reported, including cases with adenoid cystic carcinoma (ACC)-like changes. Primary cutaneous ACC is a low-grade malignancy presenting as a subcutaneous mass with the potential for local invasion, perineural invasion, and high rates of local recurrence after excision. The diagnosis of spiradenomas with ACC-like features can be challenging, especially when only the ACC-like component is present for evaluation. A retrospective analysis of 21 cases of spiradenoma with ACC-like changes were obtained from large academic institutions, was performed, and summarized below. All cases showed background of conventional spiradenoma, and the ACC-like areas represented a component in all lesions. The percentage of ACC-like component ranged from 5% to 40% in all cases. The ACC-like component was multifocal and without pleomorphism, perineural and/or vascular invasion, necrosis, or increased mitotic activity. MYB translocation and protein expression was studied in 16 cases by fluorescence in situ hybridization, polymerase chain reaction, and immunohistochemistry. All studied cases were negative for MYB / NFIB , MYB L1, and MYB F by fluorescence in situ hybridization and polymerase chain reaction and 3 cases were positive for MYB expression by immunohistochemistry. Our study expands on spiradenomas with ACC-like features that ought to be considered in the differential diagnosis of cutaneous neoplasms such as primary cutaneous ACC. Our results indicate that a thorough histopathologic inspection and strict application of well-defined histologic criteria are necessary to support the diagnosis of this unusual histopathologic variant. These tumors can be difficult to diagnose, and awareness of their histomorphologic spectrum will facilitate definitive diagnosis and avoid misdiagnosis with other conditions.

Bioptical Laboratory Pilsen Czech Republic

Department of Dermatology Columbia University New York NY

Departments of Pathology

Dermatology The Ohio State University Wexner Medical Center Columbus OH

Hospital Obrero La Paz Bolivia

Pathology Department Institute of Dermatopathology Pathology Department Zurich Switzerland

Sikl's Department of Pathology Medical Faculty in Pilsen Charles University Prague

Zobrazit více v PubMed

Kersting DW, Helwig EB. Eccrine spiradenoma. AMA Arch Derm. 1956;73:199–227.

Ter Poorten MC, Barrett K, Cook J. Familial eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2003;29:411–414.

Kazakov DV, Magro G, Kutzner H, et al. Spiradenoma and spiradenocylindroma with an adenomatous or atypical adenomatous component: a clinicopathological study of 6 cases. Am J Dermatopathol. 2008;30:436–441.

Michal M. Spiradenoma associated with apocrine adenoma component. Pathol Res Pract. 1996;192:1135–1139; discussion 1140–1141.

Eckert F, Betke M, Schmoeckel C, et al. Myoepithelial differentiation in benign sweat gland tumors. Demonstrated by a monoclonal antibody to alpha-smooth muscle actin. J Cutan Pathol. 1992;19:294–301.

Kazakov DV, Zelger B, Rütten A, et al. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome. Am J Surg Pathol. 2009;33:705–719.

Ramakrishnan R, Chaudhry IH, Ramdial P, et al. Primary cutaneous adenoid cystic carcinoma: a clinicopathologic and immunohistochemical study of 27 cases. Am J Surg Pathol. 2013;37:1603–1611.

Hopkins C, Moyer A, Huttenbach YT. Spiradenoma with adenoid cystic carcinoma-like features. Am J Dermatopathol. 2020;42:442–445.

Petersson F, Kutzner H, Spagnolo DV, et al. Adenoid cystic carcinoma-like pattern in spiradenoma and spiradenocylindroma: a rare feature in sporadic neoplasms and those associated with Brooke-Spiegler syndrome. Am J Dermatopathol. 2009;31:642–648.

Guzelbey B, Leblebici C, Koca SB. , Eccrine spiradenoma mimicking adenoid cystic carcinoma cytologically (two case reports and literature review). Diagn Cytopathol. 2022;50:E6–E12.

Shelley WB, Wood MG. A zosteriform network of spiradenomas. J Am Acad Dermatol. 1980;2:59–61.

Meybehm M, Fischer HP. Spiradenoma and dermal cylindroma: comparative immunohistochemical analysis and histogenetic considerations. Am J Dermatopathol. 1997;19:154–161.

Hashimoto K, Gross BG, Nelson RG, et al. Eccrine spiradenoma. Histochemical and electron microscopic studies. J Invest Dermatol. 1966;46:347–365.

Winkelmann RK, Wolff K. Histochemistry of hidradenoma and eccrine spiradenoma. J Invest Dermatol. 1967;49:173–180.

Watanabe S, Hirose M, Sato S, et al. Immunohistochemical analysis of cytokeratin expression in eccrine spiradenoma: similarities to the transitional portions between secretory segments and coiled ducts of eccrine glands. Br J Dermatol. 1994;131:799–807.

Mambo NC. Eccrine spiradenoma: clinical and pathologic study of 49 tumors. J Cutan Pathol. 1983;10:312–320.

Everall J, Dowd P. Multiple eccrine spiradenomata. Br J Dermatol. 1979;101(suppl 17):33–34.

Revis P, Chyu J, Medenica M. Multiple eccrine spiradenoma: case report and review. J Cutan Pathol. 1988;15:226–229.

Zhai Z, Yang X, Hao F, et al. Multiple eccrine spiradenomas in a linear or zosteriform distribution involving the right side of the body. Int J Dermatol. 2008;47:1165–1167.

Tsur H, Lipskier E, Fisher BK. Multiple linear spiradenomas. Plast Reconstr Surg. 1981;68:100–102.

Bumgardner AC, Hsu S, Nunez-Gussman JK, et al. Trichoepitheliomas and eccrine spiradenomas with spiradenoma/cylindroma overlap. Int J Dermatol. 2005;44:415–417.

Fernandez-Acenero MJ, et al. Malignant spiradenoma: report of two cases and literature review. J Am Acad Dermatol. 2001;44(suppl):395–398.

Argenyi ZB, Nguyen AV, Balogh K, et al. Malignant eccrine spiradenoma. A clinicopathologic study. Am J Dermatopathol. 1992;14:381–390.

Granter SR, Seeger K, Calonje E, et al. Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 cases. Am J Dermatopathol. 2000;22:97–103.

Biernat W, Wozniak L. Spiradenocarcinoma: a clinicopathologic and immunohistochemical study of three cases. Am J Dermatopathol. 1994;16:377–382.

Meriggi F, Tagliabò R, Morone G, et al. The potential malignancy of eccrine spiradenoma. Ital J Surg Sci. 1989;19:265–268.

Boggio R. Letter: Adenoid cystic carcinoma of scalp. Arch Dermatol. 1975;111:793–794.

Naylor E, Sarkar P, Perlis CS, et al. Primary cutaneous adenoid cystic carcinoma. J Am Acad Dermatol. 2008;58:636–641.

Yumeen S, Mirza FN, Mirza HN, et al. Primary cutaneous adenoid cystic carcinoma: characterizing US demographics, clinical course, and prognostic factors. J Am Acad Dermatol. 2021;85:245–247.

Chang SE, Ahn SJ, Choi JH, et al. Primary adenoid cystic carcinoma of skin with lung metastasis. J Am Acad Dermatol. 1999;40:640–642.

Alkan BI, Bozdogan O, Karadeniz M, et al. Two different cell populations is an important clue for diagnosis of primary cutaneous adenoid cystic carcinoma: immunohistochemical study. Case Rep Pathol. 2017;2017:7949361.

Prieto-Granada CN, Zhang L, Antonescu CR, et al. Primary cutaneous adenoid cystic carcinoma with MYB aberrations: report of three cases and comprehensive review of the literature. J Cutan Pathol. 2017;44:201–209.

Lv JJ, Ren M, Cai X, et al. Primary cutaneous adenoid cystic carcinoma: a clinicopathologic, immunohistochemical, and fluorescence in-situ hybridisation study of 13 cases. Histopathology. 2022;80:407–419.

North JP, McCalmont TH, Fehr A, et al. Detection of MYB alterations and other immunohistochemical markers in primary cutaneous adenoid cystic carcinoma. Am J Surg Pathol. 2015;39:1347–1356.

Wysocki PT, Izumchenko E, Meir J, et al. A denoid cystic carcinoma: emerging role of translocations and gene fusions. Oncotarget. 2016;7:66239–66254.

Kyrpychova L, Vanecek T, Grossmann P, et al. Small subset of adenoid cystic carcinoma of the skin is associated with alterations of the MYBL1 gene similar to their extracutaneous counterparts. Am J Dermatopathol. 2018;40:721–726.

Persson M, Andrén Y, Mark J, et al. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009;106:18740–18744.

Goto K, Kajimoto K, Sugino T, et al. MYB translocations in both myoepithelial and ductoglandular epithelial cells in adenoid cystic carcinoma: a histopathologic and genetic reappraisal in six primary cutaneous cases. Am J Dermatopathol. 2021;43:278–283.